Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.21%
#2 Ocean Protocol Ocean Protocol +21.09%
#3 KUB Coin KUB Coin +18.01%
#4 Audiera Audiera +14.74%
#5 Geodnet Geodnet +13.74%
#6 Arowana Arowana +7.88%
#7 DexNet DexNet +7.78%
#8 Cysic Cysic +7.51%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +7.30%
#10 Ontology Gas Ontology Gas +6.41%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Innstillinger
Språk
NORSK
Valuta
USD
Tema
RBC Bioscience Corporation RBC Bioscience Corporation

RBC Bioscience Corporation

6848
Rangering i aksjer #32466
RBC Bioscience Corporation is a firm dedicated to the research, development,... RBC Bioscience Corporation is a firm dedicated to the research, development, production, and sale of specialized reagents and advanced equipment. These products cater to the life sciences and molecular diagnostic sectors. Its market reach is extensive, covering Europe, the United States, Asia, Taiwan, Africa, and Australia. The company's diverse product line includes reagents tailored for molecular biomedical diagnostics and scientific research, alongside automated instruments for gene and nucleic acid extraction. It also provides a range of nucleic acid extraction kits and associated reagent tissues. Sales are primarily conducted through a global network of distributors. Established in 1995, RBC Bioscience Corporation maintains its headquarters in New Taipei City, Taiwan.
Aksjekurs
$0.71070828
Markedsverdi
$10.14M
Endring (1 dag)
1.59%
Endring (1 år)
20.26%
Land
TW
Handel RBC Bioscience Corporation (6848)

Kategori

Healthcare
Inntekter for RBC Bioscience Corporation (6848)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til RBC Bioscience Corporation er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for RBC Bioscience Corporation fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR